Skip to main content

Completed NICE / NIHR Projects

HTAs / MTAs/ DARs

Project ID
Project Title
Project lead
15/64/11

Lumacaftor in combination with ivacaftor for treating cystic fibrosis homozygous for the F508del mutation [ID786]

Joshua Pink
13/177

Canagliflozin, dapagliflozin and empagliflozin for Diabetes (monotherapy) [ID756]

NICE Guidance

Norman Waugh
13/111

Fluorouracil plasma monitoring: the My5-FU assay for guiding dose adjustment in patients receiving fluorouracil chemotherapy by continuous infusion

NICE Guidance

Paul Sutcliffe
13/178

Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control (update)

NICE Guidance

Paul Sutcliffe
13/60

Empagliflozin for type 2 diabetes

NICE Guidance

Norman Waugh
14/69/03

The LISA-TRACKER anti-tumour necrosis factor (anti-TNF) assay kits, used for monitoring anti-TNF drugs and antibodies in people with inflammatory bowel disease

NICE Guidance

KarolineFreeman
12/71 Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation
Norman Waugh
11/118 Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation Aileen Clarke
12/02/01 Clinical effectiveness and cost-effectiveness of second- and third-generation left ventricular assist devices as either bridge to transplant or alternative to transplant for adults eligible for heart transplantation: systematic review and cost-effectiveness model Paul Sutcliffe
11/130/02 Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews Paul Sutcliffe
2012/48 Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation Norman Waugh
13/08 Clinical effectiveness and cost-effectiveness of elemental nutrition for the maintenance of remission in Crohn s disease: a systematic review and meta-analysis Paul Sutcliffe
10/91 A systematic review of evidence on malignant spinal metastases: natural history and technologies for identifying patients at high risk of vertebral fracture and spinal cord compression Paul Sutcliffe


STAs

Project ID
Project title
Project lead
15/07/02

Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene [ID428]

Press release

Aileen Clarke
14/148/05

Idelalisib for chronic lymphocytic, previously treated leukaemia

NICE Guidance

Aileen Clarke
14/56

LDK378 for previously treated anaplastic-lymphoma-kinase-positive non-small-cell lung cancer [ID729]

NICE Guidance

James Mason
15/69/07

Ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer

Aileen Clarke